The organization said the health and safety of its attendees, exhibitors and staff is its "primary consideration" but did not give any indication if vaccination will be required.
The new requirement covers all attendees, including exhibitors and HIMSS employees. The organization is still determining how it will validate each person's status.
Additionally, a majority of rads said they would like to include follow-up recommendations in their reporting but 60% never use structured templates to do so.
Researchers explored data from the GALACTIC-HF trial to evaluate how the severity of a patient's reduced ejection fraction impacts the benefits of omecamtiv mecarbil.